星網宇達(002829.SZ):目前光電吊艙主要產品包括機載光電吊艙、車載/船載光電轉塔、船載光電取證
格隆匯12月9日丨星網宇達(002829.SZ)在投資者互動平台表示,民用市場方面,公司將會圍繞既有業務優勢,積極開拓更多的民品業務機會。公司研發出的光纖、MEMS等系列化慣性導航和組合導航產品可廣泛應用於鐵路檢測、智能交通、機器人、無人採煤機、飛行滑板等民用領域和場景。公司的安防雷達可用於橋樑防撞、智慧養殖(海洋牧場)等民用領域。公司的光電吊艙應用範圍也逐漸由軍用領域向民用領域擴展,目前光電吊艙主要產品包括機載光電吊艙、車載/船載光電轉塔、船載光電取證。此外,公司開展了全天候多災種全域災情偵測無人機的研發,該型無人機主要面向民用應急場景。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.